FDA Approved: BUSULFEX — Supplemental Application (Otsuka America Pharmaceutical, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Busultex (busulfan) filed by Otsuka America Pharmaceutical, Inc. The action updates the labeling to support its use …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Aplastic Anemia
• Chronic Myeloid Leukemia
• Hodgkin Lymphoma
• Myelodysplastic Syndrome
• Non-hodgkin Lymphoma

Drugs mentioned

• Busulfex (busulfan)

Snippet

SUPPL AP for BUSULFEX (BUSULFAN)